Jim Simons V Tv Therapeutics Inc. Transaction History

Renaissance Technologies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.39 - $0.84 $4,467 - $9,623	-11,456 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.51 - $1.0 $5,842 - $11,456	11,456 New	11,456 $8,000
Q1 2021 May 13, 2021	SELL	$1.97 - $2.89 $148,758 - $218,229	-75,512 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.49 - $3.1 $112,512 - $234,087	75,512 New	75,512 $140,000
Q3 2020 Nov 13, 2020	SELL	$1.7 - $2.98 $225,681 - $395,606	-132,754 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.74 - $3.19 $282,819 - $518,502	-162,540 Reduced 55.04%	132,754 $299,000
Q1 2020 May 14, 2020	BUY	$1.63 - $3.75 $418,256 - $962,246	256,599 Added 663.13%	295,294 $564,000
Q4 2019 Feb 13, 2020	BUY	$1.37 - $1.97 $53,012 - $76,229	38,695 New	38,695 $66,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.42B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.